Paulo Andrez is an angel investor, serial entrepreneur, international expert in entrepreneurship and innovation, business development, scaling up and risk mitigation.
He is the author of the Amazon bestseller "Zero Risk Startup", published by Forbes in May 2024.
He owns a significant portfolio of investments in startup and scale up companies. As an angel investor, he received the award “Best European Angel Investment” in 2012 as one of his investments (United Resins) reached 24.5 million euros in revenues within the first year of operations. One of his early-stage investments (Sword Health) became unicorn in 2022.
In 2000, he played a pivotal role as one of the key shareholders in Novabase's IPO on Euronext.
Paulo is a founder of Entrepreneurship Agency DNA Cascais, which supported more than 500 startups. Paulo was appointed President Emeritus EBAN, European Business Angel Network, after serving as President until 2014.
He has a background as serial entrepreneur and is frequently invited as speaker worldwide, guest lecturer and expert in innovation, entrepreneurship and early stage investment. Since 2012, Paulo has been holding a series of workshops on the topic of new ventures risk mitigation: Zero Risk Startup.